Our read is that taking prebiotics is well supported, particularly for specific health benefits and gut microbiome support.
Our read is that prebiotics, such as resistant starch and inulin, are well-supported for their potential to benefit the gut microbiome, reduce cancer incidence, and improve metabolic markers.
However, our sources also indicate that prebiotics may not always be beneficial, with some individuals experiencing adverse effects, and their necessity might be limited to those with dysbiosis.
The data supporting prebiotics is considered stronger than that for probiotics, though some studies on specific prebiotics have yielded conflicting results.
Paul Saladino uses a prebiotic oligosaccharide from Microbiome Labs and consumes honey daily. Bryan Johnson takes 12g of chicory inulin and 30g of resistant starch daily. Rhonda Patrick noted a study where 40g of resistant starch was consumed daily along with 300g of lean red meat.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Andrew Huberman cautioned that consuming rapidly fermentable fibers alongside a Western diet may lead to adverse liver metabolism and hepatocellular carcinoma in mice, and that taking excessive amounts of prebiotics and probiotics in capsule form on an ongoing basis can lead to brain fog. Paul Saladino reported that Robb Wolf found incorporating resistant starch made him feel horrible and was difficult to implement correctly, and that forcing prebiotics on individuals with IBS or inflammatory bowel disease can flare their disease and increase the likelihood of needing immunosuppressive drugs or surgery. Paul Saladino also stated that resistant starch may not always be beneficial for the microbiome and that there is no observed benefit to consuming resistant starch in the human diet. Andrew Huberman noted that some studies show prebiotics can significantly decrease microbiota diversity, and that studies on inulin's effects on glucose and cholesterol have yielded conflicting results. Andrew Huberman also suggested that prebiotics and probiotics are likely only necessary for individuals experiencing dysbiosis. Paul Saladino mentioned that resistant starch processed by colon bacteria leads to increased turnover and release of lipopolysaccharide from gram-negative bacteria.
The verdict would change if new evidence emerged consistently demonstrating significant harm from prebiotic consumption across diverse populations, or if further studies definitively showed no benefit for gut health or other markers in healthy individuals. Additionally, if research clarified that the adverse effects observed in some individuals are widespread rather than specific to certain conditions or types of prebiotics, the verdict would need re-evaluation.
The effect size is large enough to matter clinically, not just statistically.
Mechanistic and trial evidence converge on a real, replicable effect.
Benefits hold across the populations where it's been tested.
Inulin stimulates the growth of Bifidobacteria species in the human colon.
The intervention improves the primary outcome at standard doses in healthy adults.
Confounding and publication bias inflate the apparent benefit.
Animal-model results don't translate to the human protocol being recommended.
The headline effect shrinks once you account for trial quality.
Confounding and publication bias inflate the apparent benefit.
Animal-model results don't translate to the human protocol being recommended.